OBJECTIVE: To forecast the burden of symptomatic knee osteoarthritis (OA) in the elderly US population over a 10-year horizon. DESIGN: Using a computer simulation model of the natural history and management of knee OA combined with population-based data from the 2008 US Census we projected the 10-year burden of knee OA among persons 60-64 years of age. Knee OA incidence and progression rates were derived from national cohorts and calibrated to published literature. RESULTS: Using national data we estimated that 13% of 14,338,292 adults 60-64 years old have prevalent symptomatic, radiographic knee OA. Among persons surviving the next decade, 20% will have symptomatic advanced (Kellgren-Lawrence [K-L] grade 3) or end-stage (K-L 4) knee OA. Prevalence of advanced knee OA will range from 10% among non-obese to 35% among obese persons. Our estimates show that a more sensitive imaging tool, such as magnetic resonance imaging (MRI), may increase the number of OA cases diagnosed by up to 94% assuming that 50% of all 'pre-radiographic knee OA' (K-L 1) has some evidence of cartilage degeneration seen on MRI. CONCLUSIONS: Projecting new and advanced cases of knee OA among persons aged 60-64 years over the next decade creates a benchmark that can be used to evaluate population-based benefits of future disease-modifying OA drugs that are currently undergoing testing at various stages.
OBJECTIVE: To forecast the burden of symptomatic knee osteoarthritis (OA) in the elderly US population over a 10-year horizon. DESIGN: Using a computer simulation model of the natural history and management of knee OA combined with population-based data from the 2008 US Census we projected the 10-year burden of knee OA among persons 60-64 years of age. Knee OA incidence and progression rates were derived from national cohorts and calibrated to published literature. RESULTS: Using national data we estimated that 13% of 14,338,292 adults 60-64 years old have prevalent symptomatic, radiographic knee OA. Among persons surviving the next decade, 20% will have symptomatic advanced (Kellgren-Lawrence [K-L] grade 3) or end-stage (K-L 4) knee OA. Prevalence of advanced knee OA will range from 10% among non-obese to 35% among obesepersons. Our estimates show that a more sensitive imaging tool, such as magnetic resonance imaging (MRI), may increase the number of OA cases diagnosed by up to 94% assuming that 50% of all 'pre-radiographic knee OA' (K-L 1) has some evidence of cartilage degeneration seen on MRI. CONCLUSIONS: Projecting new and advanced cases of knee OA among persons aged 60-64 years over the next decade creates a benchmark that can be used to evaluate population-based benefits of future disease-modifying OA drugs that are currently undergoing testing at various stages.
Authors: W Zhang; M Doherty; G Peat; M A Bierma-Zeinstra; N K Arden; B Bresnihan; G Herrero-Beaumont; S Kirschner; B F Leeb; L S Lohmander; B Mazières; K Pavelka; L Punzi; A K So; T Tuncer; I Watt; J W Bijlsma Journal: Ann Rheum Dis Date: 2009-09-17 Impact factor: 19.103
Authors: R Altman; E Asch; D Bloch; G Bole; D Borenstein; K Brandt; W Christy; T D Cooke; R Greenwald; M Hochberg Journal: Arthritis Rheum Date: 1986-08
Authors: Toni L Glover; Burel R Goodin; Christopher D King; Kimberly T Sibille; Matthew S Herbert; Adriana S Sotolongo; Yenisel Cruz-Almeida; Emily J Bartley; Hailey W Bulls; Ann L Horgas; David T Redden; Joseph L Riley; Roland Staud; Barri J Fessler; Laurence A Bradley; Roger B Fillingim Journal: Clin J Pain Date: 2015-12 Impact factor: 3.442
Authors: Tara S Rogers-Soeder; Nancy E Lane; Mona Walimbe; Ann V Schwartz; Irina Tolstykh; David T Felson; Cora E Lewis; Neil A Segal; Michael C Nevitt Journal: Arthritis Care Res (Hoboken) Date: 2020-01 Impact factor: 4.794
Authors: Richard B Souza; Charles Fang; Anthony Luke; Samuel Wu; Xiaojuan Li; Sharmila Majumdar Journal: Clin Biomech (Bristol, Avon) Date: 2011-11-25 Impact factor: 2.063
Authors: E Losina; M E Daigle; L G Suter; D J Hunter; D H Solomon; R P Walensky; J M Jordan; S A Burbine; A D Paltiel; J N Katz Journal: Osteoarthritis Cartilage Date: 2013-02-04 Impact factor: 6.576
Authors: E Losina; G Michl; J E Collins; D J Hunter; J M Jordan; E Yelin; A D Paltiel; J N Katz Journal: Osteoarthritis Cartilage Date: 2015-12-31 Impact factor: 6.576
Authors: Jeffrey N Katz; Christine E Chaisson; Brian Cole; Ali Guermazi; David J Hunter; Morgan Jones; Bruce A Levy; Lisa A Mandl; Scott Martin; Robert G Marx; Clare Safran-Norton; Frank W Roemer; Debra Skoniecki; Daniel H Solomon; Kurt P Spindler; John Wright; Rick W Wright; Elena Losina Journal: Contemp Clin Trials Date: 2012-09-05 Impact factor: 2.226
Authors: Elena Losina; Alexander M Weinstein; William M Reichmann; Sara A Burbine; Daniel H Solomon; Meghan E Daigle; Benjamin N Rome; Stephanie P Chen; David J Hunter; Lisa G Suter; Joanne M Jordan; Jeffrey N Katz Journal: Arthritis Care Res (Hoboken) Date: 2013-05 Impact factor: 4.794
Authors: Alexander M Weinstein; Benjamin N Rome; William M Reichmann; Jamie E Collins; Sara A Burbine; Thomas S Thornhill; John Wright; Jeffrey N Katz; Elena Losina Journal: J Bone Joint Surg Am Date: 2013-03-06 Impact factor: 5.284